28 Stocks Moving in Friday's Pre-Market Session

Gainers

• Genetic Technologies Limited GENE rose 27.5% to $4.40 in pre-market trading. Genetic Technologies, last week, regained compliance with Nasdaq stockholders equity requirement.
• Eastman Kodak Company KODK rose 19.6% to $7.09 in pre-market trading. Southeastern Asset Management reported a 15.8% stake in Eastman Kodak.
• Social Capital Hedosophia Holdings Corp. II IPOB rose 16.4% to $14.44 in pre-market trading. Property technology startup Opendoor is in advanced discussions with billionaire Chamath Palihapitiya's blank-check company to go public in a deal that could be valued at near $5 billion, Bloomberg reported Thursday. Social Capital Hedosophia Holdings is in talks with investors to raise fresh equity to fund the merger with Opendoor.
• Fangdd Network Group Ltd. DUO rose 13.8% to $7.70 in pre-market trading. Fangdd Network Group released quarterly results last month.
• Peloton Interactive, Inc. PTON rose 12% to $98.25 in pre-market trading after the company reported better-than-expected Q4 results and issued strong Q1 sales guidance.
• Zumiez Inc. ZUMZ rose 10.3% to $27.79 in pre-market trading after reporting upbeat results for its second quarter.
• LightPath Technologies, Inc. LPTH shares rose 9.9% to $2.45 in pre-market trading after swinging to a profit in the fourth quarter.
• XpresSpa Group, Inc. XSPA shares rose 9.7% to $2.10 in pre-market trading after declining over 7% on Thursday. XpresSpa, later during August, announced a $35.5 million registered direct offering priced at-the-market under Nasdaq rules.
• Galapagos NV GLPG rose 8.4% to $136.31 in pre-market trading following press release highlighting Phase 2a trial for Ziritaxestat in patients with diffuse cutaneous systemic sclerosis met primary endpoint.
• Daqo New Energy Corp. DQ shares rose 7.7% to $104.00 in pre-market trading. Daqo New Energy, last month, reported better-than-expected Q2 sales.
• EyePoint Pharmaceuticals, Inc. EYPT rose 6.3% to $0.54 in pre-market trading. EyePoint Pharmaceuticals, last month, secured new purchase and marketing agreement with Vantage Outsourcing for DEXYCU.
• Kensington Capital Acquisition Corp. KCAC rose 6.3% to $19.39 in pre-market trading. Quantumscape, last week, said it will list on the NYSE through merger with Kensington Capital Acquisition Corp.
• Novavax, Inc. NVAX rose 6.1% to $98.54 in pre-market trading on continued strength after AstraZeneca recently paused its coronavirus vaccine study.
• Novan, Inc. NOVN rose 5.7% to $0.5580 in pre-market trading after surging around 28% on Thursday. The company yesterday tweeted '$NOVN is assessing in vitro the ability of our proprietary NITRICIL technology to inhibit the replication mechanism of #SARS-COV-2. #COVID19.'
• Penn National Gaming, Inc. PENN rose 5.2% to $65.72 in pre-market trading. Penn National Gaming shares gained over 7% on Thursday after Rosenblatt initiated coverage on the stock with a Buy rating and an $80 price target.
• Grifols, S.A. GRFS rose 5.1% to $16.40 in pre-market trading. Grifols recently announced it will acquire the remaining stake in Alkahest for $146 million.
• FuelCell Energy, Inc. FCEL rose 5.1% to $2.28 in pre-market trading. FuelCell Energy shares dropped more than 17% on Thursday after the company reported worse-than-expected Q3 earnings.
• Overstock.com, Inc. OSTK rose 4.6% to $77.95 in pre-market trading. Overstock.com shares gained 8% on Thursday after the company's tZERO subsidiary received Financial Industry Regulatory Authority approval to launch tZERO Markets.
• Oracle Corporation ORCL rose 3.4% to $59.30 in pre-market trading after the company reported stronger-than-expected results for its fiscal first quarter.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

• Amyris, Inc. AMRS fell 10.2% to $2.82 in pre-market trading. LAVVAN issued a press release highlighting it filed a $881 million Federal Suit against Amyris for patent infringement and trade secret misappropriation.
• Brigham Minerals, Inc. MNRL fell 10.1% to $8.37 in pre-market trading after the company announced a common stock offering of approximately 4.366 million shares priced at $8.20 per share and also reported a 436,000 buyback plan.
• GTT Communications, Inc. GTT fell 10.1% to $5.25 in pre-market trading. Earlier during the week, Bloomberg reported that GTT is nearing a sale of its European assets to Macquarie and 3I Group.
• Kubient, Inc. KBNT shares fell 8.4% to $3.61 in pre-market trading. Kubient, last month, priced its upsized 2.5 million unit IPO at $5 per unit.
• Satsuma Pharmaceuticals, Inc. STSA shares fell 7.3% to $5.21 in pre-market trading after Credit Suisse and SVB Leerink downgraded the stock. Satsuma Pharmaceuticals shares tumbled 76% on Thursday after reporting topline results from EMERGE Phase 3 trial of STS101 for acute treatment of migraine.
• Moxian, Inc. MOXC fell 6.6% to $2.11 in pre-market trading. Moxian, earlier during the month, reported a share exchange deal with Btab Group.
• Quotient Limited QTNT shares fell 4% to $4.63 in pre-market trading after the company reported the upsize and pricing of a $75 million underwritten public offering.
• Evofem Biosciences, Inc. EVFM fell 3% to $2.64 in pre-market trading after declining around 10% on Thursday. Evofem Biosciences recently highlighted the US commercial launch of Phexxi.
• Dave & Buster's Entertainment Inc PLAY fell 2.2% to $17.63 in pre-market trading. Dave & Buster's reported a narrower-than-expected loss for the second quarter, while sales missed estimates. The chain also declined to issue forecast for fiscal 2020.